Hutchmed (HCM) is up 10.4%, or $1.70 to $18.07.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCM:
- Hutchmed’s Phase III Study on HMPL-306: A Potential Game-Changer for AML Treatment
- HUTCHMED (China) Buy Rating: Strategic Growth Amidst Market Challenges
- Hutchmed Reports Strong Interim Results Amid Strategic Growth
- Hutchmed reports 1H EPS $2.61 vs. 15c last year
- Hutchmed sees FY25 Oncology/Immunology revenue $270M-$350M